Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenografts Development From Surgical Specimens of Triple Negative or Luminal B Breast Cancer
NCT04133077Recruiting
- Sponsor
- Centre Jean Perrin
- Start
- Nov 2021
- Primary completion
- Aug 2030
- Countries
- 1
01
Overview
Single-arm trial in breast cancer, sponsored by Centre Jean Perrin. Primary endpoint: Percentage of successful Patient Derived Xenografts (PDX) at 2 years. Started Nov 2021; status: recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04133077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04133077.